Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Head & Neck 1Genitourinary 1CNS 1Breast 1

Conditions

Urinary Bladder Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Head and Neck Neoplasms 1Esthesioneuroblastoma, Olfactory 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms 1

Interventions

Radiosurgery 8Docetaxel 4Cisplatin 4Carboplatin 4Magnetic Resonance Spectroscopy 3Filgrastim 3pembrolizumab 2Specimen Handling 2Radiotherapy 2Paclitaxel 2Nivolumab 2Mental Status and Dementia Tests 2Memantine 2Fluorodeoxyglucose F18 2Etoposide 2temsirolimus 1sargramostim 1sacituzumab govitecan 1regorafenib 1pentetreotide 1pazopanib 1molibresib 1etoposide phosphate 1etirinotecan pegol 1entinostat 1durvalumab 1cc-486 1budigalimab 1berzosertib 1atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Small Cell Lung Carcinoma × Hypericum extract LI 160 × CNS × Clear all
NCT00041171 2016-07-12

Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery

Alliance for Clinical Trials in Oncology

Phase 3 Withdrawn
BreastCNSGenitourinaryHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Head and Neck Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Esthesioneuroblastoma, Olfactory, Small Cell Lung Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡